A Randomized, Double‐Blind, Placebo‐Controlled Study of Gelesis100: A Novel Nonsystemic Oral Hydrogel for Weight Loss

OBJECTIVE: This study aims to assess the efficacy and safety of Gelesis100, a novel, nonsystemic, superabsorbent hydrogel to treat overweight or obesity. METHODS: The Gelesis Loss Of Weight (GLOW) study was a 24‐week, multicenter, randomized, double‐blind, placebo‐controlled study in patients with B...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Obesity (Silver Spring)
Main Authors: Greenway, Frank L., Aronne, Louis J., Raben, Anne, Astrup, Arne, Apovian, Caroline M., Hill, James O., Kaplan, Lee M., Fujioka, Ken, Matejkova, Erika, Svacina, Stepan, Luzi, Livio, Gnessi, Lucio, Navas‐Carretero, Santiago, Alfredo Martinez, J., Still, Christopher D., Sannino, Alessandro, Saponaro, Cosimo, Demitri, Christian, Urban, Lorien E., Leider, Harry, Chiquette, Elaine, Ron, Eyal S., Zohar, Yishai, Heshmati, Hassan M.
Formato: Artigo
Idioma:Inglês
Publicado em: John Wiley and Sons Inc. 2018
Assuntos:
Original Articles
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6587502/
https://ncbi.nlm.nih.gov/pubmed/30421844
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/oby.22347
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados